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ABSTRACT 
RECOMBINANT MOJASTINS AND THEIR AFFECT ON THE INDUCTION OF 
APOPTOSIS IN HUVEC 
by Victoria Lynn Tran 
The mojastin disintegrin, isolated from Crotalus scutulatus scutulatus snake 
venom, has been shown to inhibit platelet aggregation. However, the use of disintegrins 
has also been suggested for the treatment of metastasis. Disintegrins bind to specific 
integrin receptors, via the Arg-Gly-Asp motif (RGD-loop ), to induce cell migration, 
proliferation, and apoptosis. The specificity of the disintegrin to a particular integrin has 
been attributed to C-terminal amino acids immediately following the RGD tripeptide. 
Thus mutating one or two amino acids in this region of mojastin (RGDWN) may cause 
mojastin to bind to apoptosis affecting integrins. In this study four recombinant proteins 
(RGDDM, RGDMP, RGDWP, and RGDNN) were produced and tested for their ability 
to induce apoptosis. The results showed that the mojastin wild-type and four mutant 
fusion proteins did not induce apoptosis in HUVEC cells. This data suggests that other 
portions of the disintegrin molecule are important for integrin recognition. 
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1. Introduction 
1.1 The Emerging Role ofApoptosis in Treating Metastatic Cells 
One of the characteristics of cancer is metastasis, the ability of a cell to break free 
from the surrounding extracellular matrix, migrate, and invade other organs. The most 
effective cancer therapeutic is targeted at killing these invasive cells rather than inducing 
cell senescence (Meng et al., 2006). Successful cancer therapeutics cause neoplastic cells 
to undergo apoptosis, ultimately preventing both proliferation and migration of cancer 
cells. Apoptosis is an essential part of cell development. In order for humans to develop 
fingers and toes or to form new synapses in the brain, requires the removal of extraneous 
cells. Apoptosis is also a way to remove cells that threaten the structural organization 
which allows multicellular organisms to thrive (Kerr et al., 1972). 
1.2 The Interaction of Cell Surface Receptors and Signaling Systems They Affect 
In a homeostatic environment cells, within a multicellular organism have 
extracellular and intracellular signals that convey cell boundaries and are the basis for the 
formation of tissues. Cells interact with the extracellular matrix (ECM) through the 
binding of ECM adhesion molecules and cell surface receptors, one of which is a family 
of receptors known as integrins. Integrins are transmembrane receptors composed of a 
combination of different alpha and beta subunits. Depending upon the combination of 
the alpha and beta subunit, an integrin bound to insoluble proteins (fribonectin and 
vitronectin), soluble proteins (disintegrins), or neighboring cells, transfers a signal that 
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induces the cell to migrate, proliferate, or undergo apoptosis. Recent cancer research has 
capitalized on the role of integrins in the signaling of apoptosis and focused on finding 
antagonist molecules that will induce this signal (Aguzzi et al., 2004). 
Among these molecules are disintegrins, a low molecular weight, snake venom 
proteins that are released as part of a larger protein, matrix metolloprotease, known as 
snake venom metalloprotease (SVMP), or after proteolytic cleavage as a monomer or 
dimer (Ramos et al., 2008). Disintegrins are non-enzymatic molecules, with a cysteine 
rich portion, and a tripeptide (arginine/glycine/aspartic acid) called the RGD-loop. In its 
tertiary arrangement the cysteine rich portion forms disulfide bonds creating a hairpin 
loop, exposing the RGD tripeptide in the loop region (McLane et al., 2004). The RGD-
loop when bound to an integrin provides potency of signal and the amino acids 
immediately flanking the RGD tripeptide, in the N-terminal and C-terminal regions, 
provide specificity and affinity for a particular integrin (Kini, 1998; Rahman et al., 1998). 
Other tripeptide binding motifs include KGD, MVD, MLD, VGD, ECD, and MDG (Lu et 
al., 2006). 
1.3 RGD-Loop and Disintegrin Specificity 
The binding specificity and affinity of integrins has been attributed to the amino 
acids flanking the RGD-loop of disintegrins (Kini and Evans, 1995a; Kini and Evans, 
1995b; Rahman et al., 1998). In experiments where Kini and Evans (1995) replaced two 
amino acids, one in the N-terminal and one in the C-terminal region adjacent to the RGD-
loop of the peptide IARGDMNA, with a Pro residue, converting it to IPRGDMP, they 
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found that the antiplatelet activity increased by up to 13-fold. Rahman et al. (1998) 
found that by replacing the N-terminal and C-terminal amino acids flanking the RGD-
loop of elagantin, changing the 50th amino acid from Ala to Pro, and the 54th amino acid 
from Met to Asn, they were able to affect inhibitory potency of elagantin (Figure 1). To 
this end, the mojastin disintegrin was mutated at the 54th and 55th amino acids (the two 
amino acids immediately C-terminal to the RGD tripeptide) to mimic those of echistatin 
(RGDDM) and rhodostomin (RGDMP). In vivo studies have shown the induction of 
apoptotic activity of endothelial cells after exposure to accutin, agkisrin-s, echistatin, and 
rhodostomin (Brassard et al., 1999; Ren et al., 2006; Wu et al., 2003; Yeh et al., 1998). 
These disintegrins bind to avP3 and asPi integrin receptors phosphorylating FAK and 
inducing caspase-3 activation of apoptosis (Alimenti et al., 2004; Wierzbicka-Patynowski 
et al., 1999). Studies using recombinant disintegrins are aimed at increasing their binding 
specificity to integrins and also to improve their bioavailability (Eble and Haier, 2006). 
Mojastin, a disintegrin found in the Crotalus scutulatus scutulatus venom, has 70 
amino acids with a molecular weight of 7 kDa. Mojastin was previously shown to inhibit 
platelet aggregation in whole human blood at IC50 of 13.8 nM. However, mojastin was 
ineffective at inhibiting T24 cells, which exhibits the receptors avp3 and as Pi (Sanchez et 
al., 2006). The 0^3 and a$\ integrin receptors, have been linked to apoptosis, and bind 
both echistastin and rohodostomin. In order to alter mojastin's specificity the amino 
acids at the 54th and 55th amino acid were changed (Figure 2). 
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1. 
2. 
3. 
4. 
Elegantin 
Eg AM 
EgPN 
EgPM 
^50^-51G52D53N54P55 
A R G D M P 
P R G D N P 
P R G D M P 
Figure 1. Partial sequences of the altered elegantin. The substitutions, Asnso to Pro and 
Asn54 to Met, created in elegantin. 
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In this study we used mutant mojastin constructs provided by the Soto lab, to express 
recombinant fusion proteins and test their ability to induce apoptosis. 
1.4 The specific aims of this study were to: 
1. Express and purify recombinant GST-MO J wild-type and mutants. 
2. Determine whether changing the 54th and 55th amino acid residues, Qmmediately 
C-terminal to the RGD tripeptide, induced apoptosis in HUVEC cells. 
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2. Review of Literature 
2.1 Apoptosis: the Art of Cellular Death 
2.1.1 Historical Perspective 
The morphology of cellular death was first observed by Carl Vogt in 1842 (Peter 
et al., 1997). However, the term apoptosis, a Greek description for falling off or 
dropping off, was introduced into literature in 1972 by Kerr et al. Apoptosis is 
characterized by cell shrinkage, detachment from surrounding cells, nuclear 
condensation, DNA fragmentation, membrane blebbing, and the formation of apoptotic 
bodies. These apoptotic bodies are eventually phagocytized by surrounding cells and 
macrophages or escape the cell lumen where they undergo necrosis (Wyllie, 1992). 
Apoptosis is critical for the development and structural organization of multicellular 
organisms. This observation is best exemplified in the embryonic development of 
Caenorhabditis elegans. 
2.1.2 A Simple Model of the Apoptosis Signaling Cascade 
In the development of hermaphroditic C. elegans, 131 of the 1090 cells had a 
predetermined time of death indicating that cell disposal was the result of genetic control 
(Peter et al., 1997). In C. elegans, ced-3 and ced-4 are proapoptotic genes and ced-9 
negatively regulates apoptosis. CED-3 is a cysteine protease and initiates apoptosis, 
when cleaved by CED-4. CED-9 binds to CED-4, which is in turn bound to the CED-3 
zymogen, to form a complex that represses the proteolytic activity of CED-4. Binding of 
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CED-9 with EGL-1 displaces CED-4, releasing CED-4, and enabling it to activate the 
CED-3 zymogen, thus initiating apoptosis (Borner, 2003; Hengartner and Bryant, 2000; 
Kaufmann and Hengartner, 2001; Peter et al., 1997; Wyllie, 1997). The caspases, Apaf-
1, and Bcl-2 are mammalian homologues of CED-3, 4, and 9, respectively. However, the 
apoptotic signaling mechanism in mammals differs from those of C. elegans. 
2.1.3 Starting from the Top: Extrinsic and Intrinsic Signaling 
Although the mammalian signaling cascade for apoptosis is much more 
complicated, the homologues of CED-3,4, and 9, in mammals, still share the same 
general roles. Similar to CED-3, caspases are the initiators and effectors of apoptosis. 
Apaf-1, like CED-4, forms a complex that acts on the caspases. The members of the 
BCL-2 family of proteins, which are homologous to CED-9, regulate the apoptosis 
machinery. Initiator caspases-8 and 9 are activated by different signaling mechanisms 
but share commonalities in their downstream cascade and converge upon activation of 
caspase-3 and 7. 
The signals that activate initiator caspases may be extrinsic or intrinsic. The 
extrinsic pathway starts with ligand binding, then clustering of death receptors (DR) 
belonging to the superfamily of tumor necrosis factor receptor (Kaufmann and 
Hengartner, 2001; Vermeulen et al., 2005). Members of this family include Fas, Tumor 
Necrosis Factor (TNF)-receptor-l, and other DRs, including DR-3, 4, 5 and 6. A 
common example of extrinsic signaling involves binding of the Fas receptor with Fas 
ligand. This causes trimerization of the Fas receptor leading to the recruitment of the 
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Fas-associated death domain protein (FADD) and procaspase-8 or 10, forming the death 
inducing signal complex (DISC). FADD is an adaptor molecule that has a death domain 
(DD), that binds to Fas and a death effector domain (DED) which in turn binds to the 
DED domain portion of procaspase-8. Due to its proximity to one another, procaspase-8 
undergoes autoproteolysis (Hengartner, 2000) forming caspase-8 which then activates 
procaspase-3 and 7. Caspase-3 and 7 are responsible for the morphological changes that 
are characteristic of apoptosis. 
DNA damage, oxidative stress, starvation, or chemotherapeutics (Borner, 2003) 
cause the releases cytochrome-c from the mitochondria into the cytoplasm, initiating the 
intrinsic pathway. Cytochrome-c binding in the presence of ATP causes a 
conformational change to the apoptotic protease activating factor-1 (Apaf-1), increasing 
its affinity for procaspase-9. Binding of the caspase recruitment domain (CARD) portion 
of Apaf-1 to the CARD of procaspase-9, results in the formation of a complex called the 
apoptosome. Activated caspase-9, within the apoptosome, can then act on caspase-3 and 
7 leading toward apoptosis. 
2.1.4 Bcl-2 Family: Regulating Apoptosis 
As mentioned above, the Bcl-2 family of proteins in mammals is homologous to 
CED-9 of C. elegans. Proteins in the Bcl-2 family share one or more of four common 
Bcl-2 homology domains (BH1-BH4) and can be grouped according to their ability to 
either promote apoptosis or cell survival. Antiapoptotic Bcl-2 members include Bcl-2, 
Bcl-B, Bcl-Xi, Bcl-W, Bfl-l/Al, and Mcl-1, while proapoptotic Bcl-2 family members 
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can be further divided into the Bax-family (Bax, Bak, and Bok/Mtd) and the BH3 only 
family (Bid, Bad, Bmf, Hrk/DP5, Noxa, and Puma) (Vermeulen et al., 2005). Though the 
exact mechanism of regulation by the Bcl-2 family members is still under debate, the role 
of Bcl-2 as a regulator of apoptosis is clear. 
Under homeostatic conditions Bax exists in the cytosol, and Bak in the 
mitochondria in their monomeric form. However, under stimuli such as DNA damage, 
starvation, or cell detachment, BH3-only member proteins are upregulated causing the 
tranfers of the death signal to the mitochondria. Bax and Bak are sequestered to the outer 
mitochondrial membrane where they homodimerize. It is unclear whether Bax/Bak, form 
membrane channels or whether they facilitate the opening of voltage gated channels, but 
their presence causes the permeabilization of the outer mitochondrial membrane. This 
results in the release of cytochrome-c into the cytoplasm (Borner, 2003; Chowdhury et 
al., 2006; Vermeulen et al., 2005) and the onset of the intrinsic signaling pathway of 
apoptosis. Antiapoptotic Bcl-2 family members such as Bcl-2 and Bcl-X] are believed to 
regulate proapoptotic signals by maintaining outer mitochondria membrane integrity, 
though the mechanism has yet to be determined. 
2.2 Integrin Signaling and the Consequences of Extracellular Matrix Detachment 
In tissues, cells attach themselves to the extracellular matrix through receptor 
binding of integrins with cell adhesion molecules. The specific binding of integrins 
(avP3, and a5pi) leads to clustering of similar integrins on the cell membrane surface. 
This clustering recruits focal adhesion molecules such as talin, viniculin, Src, and FAK 
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(Matter and Ruoslahti, 2001). FAK, focal adhesion kinase, causes phosphorylation of 
phoshotidyl-inositol-1, 3, 4-diphosphate (PIP2) to form phoshotidyl-inositol-1, 3, 4, 5-
triphosphate (PIP3) to act on PKB/Akt molecules which inhibit the activity of 
proapoptotic Bcl-2 family members such as Bad, Bim, and Bax, thus suppressing 
apoptosis. In the absence of this inhibition by PKB/Akt, due to detachment from the 
substratum or antagonistic binding of integrin receptors, the proapoptotic molecules 
translocate to the outer mitochondrial membrane, initiating the intrinsic apoptosis 
signaling pathway (Barja-Fidalgo et al., 2005; Bouchard et al., 2008; Grossmann, 2002). 
2.3 Detection of Apoptosis 
Annexin V binds with high affinity and specificity to phosphotidyl serine a 
membrane phospholipid. In viable cells phophotidyl serine faces the cytosol. During the 
early stages of apoptosis phosphotidyl serine flips and is exposed to the extracellular 
matrix (Vermes and Haanen, 1994). However the integrity of the membrane is 
maintained, differentiating these apoptotic cells from necrotic cells, which loose 
membrane integrity and exhibit membrane leakage. Using Annexin V attached to 
fluorescein isothiocyannate (FITC), a green fluorescence molecule, and a counter stain 
propidium iodide, a red fluorescence molecule, the number of apoptotic cells in a 
population may be quantified. 
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3. Methods 
3.1 Transformation of Escherichia coli 
PGEX-KG vectors containing the mutated mojastin constructs, developed by 
researchers in the Soto lab, were added to 100 ul of E.coli BL21-GOLD (Strategene) or 
NEB-DH5a (New England BioSciences) competent cells and the transformation was 
carried out according to the manufacturer's instructions. The cells were left to incubate 
for 30 min on ice, while SOC medium (Stratagene), was preheated in a 42°C waterbath. 
The transformation reaction was heat-pulsed at 42°C for 20 s and incubated on ice. After 
2 min, 900 ul of warmed SOC medium was added to the reaction. The transformation 
reaction was then placed on a shaker and left to incubate at 37°C, 250 rpm for 1 h. 
Finally 20 ul of the tranformant was streaked on Lauria-Bertani agar (Fisher) with 
ampicillin plates and left to incubate at 37°C overnight. 
3.2 Fusion Protein Expression 
Eight colonies were cultured in 200 ml of 2x Yeast-Tryptophan (QBiogene) or 
Lauria-Bertani (LB) broth in the presence or absence of 10 ug/ml ampicillin. The culture 
was grown to an OD600 of 0.6-0.8 with vigorous agitation, 225 rpm, at 37°C. GST-MOJ 
was induced by adding 1 mM of isopropyl P-D-thioglalactoside (Amersham Biosciences) 
and left to incubate for an additional 2 h. The culture was then transferred to four 50 ml 
centrifuge tubes and centrifuged at 700x G for 10 min to obtain the pellet. The 
supernatant was discarded and the pellet was suspended in lx PBS (Gibco). 
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3.3 Lysis and Purification of GST-MO J 
Cells were lysed using a sonicator, 20 bursts followed by 20 s on ice. The 
supernatant was retained after centrifugation for 10 min at 700x G and applied to a 1 ml 
GSTrap column (GE Biosciences) at 0.2-1 ml/min. The column was washed 5 ml with 
lx PBS and eluted with 5 ml of reduced glutathione. Protein concentrations were 
determined using the Bradford assay. 
3.4 Molecular Weight Determination of GST-MO J using SDS-PAGE Gels 
Proteins samples were mixed with lx Laemmli Sample Buffer (BioRad) and 
boiled at 95°C for 5 min. The samples were cooled at room temperature and 40 ul was 
added to a NuPAGE 4-12 %, Bis-Tris gel (Invitrogen). The gel ran at 120 mA for 40 min 
in MES Buffer (Invitrogen). The gel was then stained with Coomassie Brilliant Blue 
(Sigma). 
3.5 Culturing HUVEC Cells 
HUVEC were a product of Lonza (C2517A) and cultured in 25 cm2 flasks with 
endothelial cell basal medium (EMB-2 Basal Medium, CC3156) supplemented with: 
BBE, 2 ml; hEGF, 0.5 ml; Hydrocortisone, 0.5 ml; FBS, 10 ml; GA-1000, 0.5 ml. They 
were incubated at 37°C with 5% CO2. The cells were subcultured once they reached 80% 
confluency. The process involved aspirating used media, washing with 5 ml of PBS, and 
detaching using 0.05% tryspin EDTA (Invitrogen). The action of trypsin was neutralized 
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with the complete culture media containing 2% bovine serum albumin. Cells were then 
split 1:2 and transferred to new 25 cm2 flasks. 
3.6 Apoptosis Detection 
HUVEC cells were cultured to 80% confluency in a 75 cm tissue culture flask 
(Fisher). Once the cells were confluent they were detached from the flask surface using 
0.05% trypsin EDTA. Trypsin was neutralized with complete culture media. The cells 
seeded in 25 cm2 flasks (Fisher) and left to attach for 4 h. The cells were then treated 
with 2.5, 5, 10, or 15 uM camptothecin; 10, 20, 50 or 100 uM echistatin; 1 or 10 uM 
GST; or 5 uM wild-type and mutant mojastin recombinant fusion proteins. The cells 
were observed and harvested after 18-20 h, with trypsin in the same manner as above. 
The cells were spun down and washed two times with cold PBS. Then they were 
resuspended in 1 ml of lx PBS. Afterward, 100 ul was removed and exposed to 5 ul each 
of Annexin V-FITC and Propidium Iodide (BD Biosciences). The reaction was left at 
room temperature for 15 min and analyzed using the FACSCalibur after 400 ul of lx 
binding buffer was added. Statistical analysis of the percent apoptotic cell population, 
using paired t-tests, was performed using InStat (GraphPad). 
3.7 Hoechst 33258 Staining 
HUVEC cells were cultured and collected as above and seeded 2.5 x 105 cells per 
slide well chamber (Nalgene). The cells were then fixed in 3% paraformaldehyde, then 
set in 100% cold methanol and stained with 10 ug/ml of Hoechst 33258 (Invitrogen). 
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4. Results 
4.1 Optimization of Culturing Conditions for Fusion Protein Expression 
The GST fusion protein expression in the E. coli NEB-DH5a strain was compared 
to those of the BL21 strain (Figure 3). At the same time the NEB-DH5a strain was 
cultured in either 2x Yeast Tryptophan or Lauria-Bertani broth. They were also cultured 
with ampicillin or without. After induction with IPTG, BL21 cells, grown in 2x YT broth 
with ampicillin (2x YTA), showed a significant increase in GST fusion protein 
expression (lane 4), whereas the NEB-DH5a cells in the same medium condition did not 
(lane 12). Moreover NEB-DH5a cells did not show an increase in GST fusion protein 
expression under any of the media conditions, 2x YT versus LB broth, and in the 
presence or absence of ampicillin. The expression of GST fusion proteins using the 
BL21 strain of E. coli in 2x YTA media, as seen from these results, was chosen for the 
continuation of this study. 
4.2 Detection of Purified GST-MOJ Fusion Protein Using SDS-PAGE 
After optimization of culture conditions, the GST-MOJ fusion proteins were 
expressed and purified using 1ml GSTrap affinity columns. SDS-PAGE was used to 
verify the purification of the GST fusion proteins from cell lysate. It was also determined 
that expression system E. coli was adequate for the production of GST-MOJ 
recombinants (Figure 4). As seen in lane 4, the pGEX-KG vector, without the mojastin 
15 
1 2 3 4 5 6 7 8 9 10 11 12 
Figure 3. Comparative expression of GST-MOJ by BL21 and NEB-DH5a 
strains of E. coli. Different culture conditions were also tested. The strains 
were cultured in either 2x Yeast Tryptophan (YT) or Lauria-Bertani (LB) 
broth with or without the addition of ampicillin (A). Samples in lanes 4, 6, 8, 
10, and 12 were induced with IPTG. Lanes 2, 5, 7, 9 and 11 were uninduced 
samples. Lane 1 contained the molecular weight standard (Biorad). Lane 2 
& 4 were lysate samples from the BL21 strain, grown in 2x YTA broth. Lane 
5 & 6 were lysate samples from the NEB-DH5a strain, grown in LB broth. 
Lane 7&8 were lysate samples from the NEB-DH5a strain, grown in LBA 
broth. Lane 9&10 were lysate samples from the NEB-DH5a strains, grown 
in 2x YT. Lane 11&12 were lysate samples from the NEB-DH5a strain, 
grown in 2x YTA. BL21 cells grown in 2x YTA showed a significant 
increase in GST-MOJ production (yellow oval). 
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Figure 4. Purification of GST-MOJ visualized by SDS-PAGE. 
Lane 1: MW; Lane 2: GST un-induced; Lane 3: GST whole 
lysate; Lane 4: GST purified; Lane 5: GST-MOJWN whole 
lysate; Lane 6: GST-MOJWN purified. 
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insert, produced a band at 29kDa, the predicted size of the GST protein, whereas pGEX-
KG with the mojastin insert produced a band at the predicted size of 34 kDa (lane 6). 
Once it was established that the GST-MOJ fusion proteins were produced using 
this approach, the GST-MOJWP, NN, DM, and MP fusions proteins (Figure 5) were 
expressed and purified (lanes 4, 6, and 8 in panel A; lane 3 in panel B). Some of the 
samples also included GST by itself (blue arrow heads). This is the result of randomly 
selecting eight E. coli colonies, after transformation of BL21 cells, for culture. Cell 
lysates were also included in lanes 3,5, and 7 of panel A and lane 2 of panel B. 
4.3 Optimization of Annexin V-FITC Detection of Apoptosis using FACSCalibur 
The ability to detect apoptosis, in an Annexin-V-FITC assay, was determined 
using camptothecin, a known inducer of apoptosis in HUVEC cells (Simak et al., 2002). 
This drug was added to HUVEC cells at 5, 10, and 15 uM concentrations and the cells 
were left to incubate for 24 h (Figure 6). Apoptosis was detected in the HUVEC cells 
exposed to camptothecin (panel B, C, and D in the lower right quadrant), however not in 
a dose dependent manner 5 uM (12.15%); 10 uM (17.21%); and 15 uM (14.53%). Also 
there was an abundance of late stage apoptotic and necrotic cells in the upper right 
quadrant and very few live cells in the lower left quadrant. This indicates that the dose 
range may be too high or that the incubation time was too long. For the succeeding 
experiments, 2.5 uM of camptothecin were used, as a positive control for apoptosis, 
allowing the visualization of the viable population of cells as well as apoptotic and 
necrotic cells. The commercially available disintegrin, echistatin, shown to induce 
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Figure 6. To determine the appropriate does for the positive control, 
HUVEC cells were exposed to 5, 10, and 15 uM of camptothecin. At 5 
uM camptothecin 12.15% of the total population of gated cells were in 
early stage apoptosis (lower right quadrant, panel B), most of the cells 
(86.56%) were in late stage apoptosis or necrosis, and only 1.19% were 
viable. Most the cells were in the upper right quadrant for doses 10 uM 
(77.42%) and 15 uM (83.29%) as well (panel C and D), indicating that the 
dose at 5 uM was either too high or the incubation time was too long. For 
the positive control either exposure to 2 or 2.5 uM of camptothecin for 24 
h should be used in order to obtain a larger population of viable cells 
(lower left quadrant). In the upper right quadrant of panel B there are two 
populations. The top population are necrotic cells (blue circle), while the 
bottom population are late stage apoptotic cells (yellow circle). 
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apoptosis in Pi cells (Alimenti et al., 2004), was also tested as a positive control for 
apoptosis (Figure 7). Unfortunately, the apoptotic responses to echistatin at 
concentrations: 10 uM (2.00%), 20 uM (1.72%), 50 uM (2.98%), and 100 uM (2.88%); 
were similar to those of untreated HUVEC cells. Echistatin was chosen to be the other 
positive control, because it has been shown to induce apoptosis in endothelial cells and it 
was commercially available. Unfortunately, the echistatin purchased from Sigma showed 
no apoptotic activity. The manufacturers of echistatin were not forthcoming about the 
methods of echistatin production and Sigma, the distributing company, did not have any 
activity data on the disintegrin. 
HUVEC cells were exposed to GST, as a negative control for apoptosis (Figure 
8). There was no increase in apoptotic activity at concentrations luM (1.24%) and 10 
uM(1.59%). 
4.4 Apoptosis Detection in HUVEC Cells after Exposure to GST-MO J Fusion Proteins 
The mojastin disintegrin (RGDWN) has been shown to inhibit ADP-induced 
platelet aggregation at IC50 13.8 nM (Sanchez et al., 2006). In this study wild-type 
recombinant fusion protein (GST-MOJWN) did not induce apoptosis at 5 uM (1.29 ± 
0.3%) figure 9. The results show that 5 uM GST-MOJWP (1.01 ± 0.2%, p > 0.05) and 5 
uM GST-MOJNN (1.58 ± 0.6%, p > 0.05) did not induce apoptosis in HUVEC cells. The 
same inactivity was observed for 5 uM GST-MOJDM (1.54 ± 0.1%, p > 0.05) and 5 uM 
GST-MOJMP (1.43 ± 0.3%, p > 0.05). 
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Figure 7. Exposure to echistatin did not illicit an apoptotic response 
in HUVEC cells. Varying concentrations of echistatin (panels C thru 
D) were added to flasks with HUVEC cells and incubated for 24 h at 
37°C. Annexin V-FITC and PI staining showed that the population 
of apoptotic cells (lower right quadrant) for echistatin induced cells 
were the same as those of untreated HUVEC cells (panel A). Mean 
while in exposure to the positive control (camptothecin) showed that 
7.07% of the gated population of HUVEC cells were apoptotic (panel 
B). 
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Figure 8. GST was tested at 1, 10 and 15 uM, for its 
affect on the viability of HUVEC cells. There was no 
change in the early stage apoptotic population (lower 
right quadrant; panels C, D, and E). However the late 
stage apoptotic and necrotic cell population did increase 
in a dose dependent manner; 5.77% at 1 uM (panel C) 
and 9.72% at 10 uM (panel D). 
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Figure 9. The apoptotic affect of 5 uM wild-type and mutant mojastin 
recombinant fusion proteins were tested on HUVEC cells. At 5 uM 
the percent of early stage apoptotic cells for each of the mutants and 
the wild-type were the similar as the untreated cells (1.41% ± 0.3). 
Statistical analysis using a paired t-test showed that the means were 
not significantly different for the wild-type and mutant mojastin 
recombinant fusion proteins as compared with the untreated sample (P 
> 0.05). This data reflects measurements taken from three different 
experiments. The bars represent ± SD. 
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Paired t-tests used to compare untreated samples and each of the other samples confirmed 
that the difference between the apoptotic cell population of wild-type and mutant 
mojastin recombinant fusion proteins and the untreated cells was not significant. 
However, when the apoptotic population of untreated cells was compared to those of 
camptothecin, there was a significant difference (p < 0.001) 
4.5 Hoechst 33258 Staining ofHUVEC Cells Exposed to GST-MO J Fusion Proteins 
Staining of the HUVEC cells after incubation with 2.5 uM Camptothecin, 5 uM 
GST-OJWN and GST-MOJNN verified the results above (Figure 10). Cells exposed to 
camptothecin exhibited nuclear condensation when stained with Hoechst 33258 (white 
arrows). Cells exposed to either GST-MOJWN and GST-MOJNN did not show any 
morphological changes that could be attributed to apoptosis. 
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^ ^ ™ 
5 uM GST-MOJWN 
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2.5 uM Cainptothecin 
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Figure 10. Apoptosis as characterized by nuclear condensed 
fragments were visualized using 10 ug/ml Hoechst 33258. HUVEC 
cells exposed to 5 uM GST-MOJWN and GST-MOJNN did not show 
an increase in nuclear condensation as compared with cells exposed 
to 2.5uM camptothecin (white arrows). 
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5. Conclusion 
5.1 Disintegrins as a Cancer Therapeutic 
Integrin binding of adhesion molecules in the extracellular matrix has been shown 
to induce signaling pathways that on the one hand result in cell migration and 
proliferation, while also suppressing signaling pathways that cause cells to undergo self 
destruction (Barja-Fidalgo et al., 2005; Zhang et al., 1995). Dysfunction in these 
signaling pathways causes tumor progression and metastasis. Thus it has been the aim of 
some cancer therapies to target ingterins and induce cell death in order to prevent the 
proliferation and migration of neoplastic cells. Disintegrins are natural antagonists of 
integrin binding with cell matrix proteins. Their binding of integrins causes cell 
detachment from the cell matrix, releasing the cell from antiapoptotic control and 
resulting in a special form of cell death called anoikis (Barja-Fidalgo et al., 2005; 
Morozevich et al., 2006). Recombinant proteins have been produced to test the binding 
affinity and specificity of disintegrins to integrins receptors (Chang et al., 2001). 
5.2 Protein Modeling: Predicting the Apoptosis Inducing Structure of Disintegrins 
Researchers in the Soto lab used site directed mutagenesis to change the 54l 
and/or 55th amino acid of the mojastin disintegrin to create ten mutants. In order to 
predict the activity of these mutants, three dimensional models were constructed using 
homology modeling. In this model a high resolution x-ray structure of trimestatin (Fujii 
et al., 2003) was used as a template for the disintegrin protein, due to the lack of 
27 
structural information available for mojastin. Trimestatin was chosen because it shared 
the highest sequence similarity to mojastin (81.7%), compared with any other medium 
length disintegrin. The mojastin sequence was aligned using trimestatin as the template 
by the program MODELLER. This produced five possible three dimensional models for 
mojastin. These models were analyzed using PROCHECK, a program that generates 
Ramachandran plots depicting the best stereochemistry for each of the models. The 
models chosen had 91% of their residues in favorable regions. This confirmed the 
reliability and stereochemical accuracy of the models produced. CHIMERA was then 
used to create a surface model which provided the best indicator of overall structure 
visually. 
Using the three-dimensional structures created in this way researchers in the Soto 
lab were able to pick four mutants, from the ten, which were most likely to affect the 
induction of apoptosis. Two of the mutants contained the same 54th and 55th amino acids 
as echistatin (RGDDM) and rhodostomin (RGDMP). Echistatin (10 ug/ml) elicited an 
apoptotic response when exposed to GD25 cells (Alimenti et al., 2004) and 4 ug/ml of 
rhodostomin induced apoptosis in HUVEC cells (Wu et al., 2003). Two others mutants 
(NN and WP) were chosen for their structural similarity in the C-terminal region to MP 
because the models showed that changes in the 54th and 55th amino acids affect a 
conformational change in the C-terminal domain of disintegrins. Thus these four mutants 
along with wild-type mojastin (Figure 11) were chosen to be expressed as GST fusion 
proteins and assayed for their ability to induce apoptosis. 
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Figure 11. Surface models for mojastin and mutant sequences. 
Mojastin (WN); the two mutants with sequence similarity to 
rhodostomin (DM) and echistatin (MP); and the two mutants 
structurally similar to echistatin (NN and WP) are presented. 
Here the RGD-loop is shown in red and the C-terminus is 
shown in green. These models were created using 
MODELLER and visualized using CHIMERA. Each model 
was analyzed using PROCHECK to determine the most 
probable stereochemistry. 
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5.3 Wild-Type and Mutant Recombinant Fusion Proteins: Inability to Induce Apoptosis 
Although, mojastin 1 and 2 inhibit platelet aggregation, the recombinant mojastin 
did not induce apoptosis in HUVEC cells, which is not surprising since mojastin did not 
inhibit T24 cells from binding fibronectin (Sanchez et al., 2006), the adhesion molecule 
bound by integrin receptors a$\ (Berman et al., 2003). However, it is surprising that 
GST-MOJDM and GST-MOJMP did not induce apoptosis in HUVEC cells. There are 
three possible explanations for my findings. Either the fusion proteins produced in this 
study were misfolded, apoptosis induced cell death due to exposure to disintegrins may 
be cell specific, or the RGD-loop recognition sequence produced was insufficient for avP3 
and (X5P1 integrin signaling of apoptosis. 
Researchers have found that disintegrins produced E. coli have biological activity. 
Recombinant elegantin (Rahman et al., 1998) and rhodostomin (Chang et al., 1993), 
expressed by E. coli as glutathione-S-transferase fusion proteins, retained their structural 
morphology and biological activity. GST-Elegantin had the same inhibitory potency 
(IC50 0.3 uM) as the purified toxin in ADP-induced platelet aggregation of platelet rich 
plasma (Rahman et al., 1998). Change et al. (1993) tested binding of human hepatoma 
cells to culture plates coated with GST-Rhodostomin (GST-RHO) or with GST by itself, 
and found that binding of human hepatoma cells to GST-RHO coated plates was 10 to 20 
fold over those culture plates without. Two synthetic peptides were created to test 
whether the binding of human hepatoma cells was specific to the RGD-loop of GST-
RHO. The first was GRGDSP, which retained the RGD sequence and the second was 
GRGESP with an Asp amino acid substituted with a Glu amino acid. Increasing amounts 
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of GRGDSP decreased the binding of human hepatoma cells to GST-RHO. However 
increasing amounts of GRGESP did not affect binding of human hepatoma cells, 
indicating that the cells were specifically binding to GST-RHO. The biological 
functionality of recombinant rhodostomin in these assays led Change et al. (1993) to 
conclude that the rhodostomin molecule bound to GST was properly folded. GST-MOJ 
and GST-MOJNN exhibited binding activity in adhesion assays performed using TD24 
cells, while GST-MOJ, GST-MOJNN, and GST-MOJDM displayed binding activity in 
adhesion studies using skin melanoma cells (E. Sanchez, personal communication, March 
6, 2008). This evidence shows that the wild-type and mutant mojastin recombinant 
fusion proteins were most likely folded properly. 
Conforti et al. (1990) inserted the isolated vitronectin receptor (av|33) into different 
types of liposomes in order to test binding affinity of avP3 receptor to vitronectin The 
different types of liposomes were phosphotydilcholine (PC), PC + 
phosphotidylethanolamine (PE), and PC + PE + phosphotidylserine (PS) + 
phosphotidylinositol (PI) + cholesterol (chol). The results of this study showed that av(33 
was able to recognize vitronectin more readily and bound to vitronectin with greater 
affinity as the liposome structure became more complex. Also avP3 receptors were able 
to bind other proteins such as von Willebrand factor and fibronectin. This suggests that 
integrins on different cells types may behave differently depending upon the cell 
membrane environment. This explanation may apply to GST-MOJDM. However, 
rhodostomin has been shown to induce apoptosis in HUVEC cells (Wu et al., 2003). 
31 
Thus some other factor must be influencing the lack in apoptotic activity of GST-
MOJMP. 
Since inhibition studies with kristin and dendroaspin, two disintegrins with the 
same sequence (PRGDMP), showed that they bound with equal avidity to am,P3, it was 
surprising that the mutants GST-MOJDM and GST-MOJMP with C-terminal residues 
adjacent to the RGD-loop similar to echistatin (RGDDM) and rhodostomin (RGDMP) 
did not induce apoptosis (Rahman et al., 1995). Kristin and dendroaspin also competed 
with each other for the same receptor binding site on ocm^ integrins (Rahman et al., 
1995), suggesting that the target for the two disintegrins is the same. Exploration of the 
N-terminal residues adjacent to the RGD-loop may produce a mojastin mutant 
recombinant fusion protein that can induce apoptosis in endothelial cells. 
Studies done with recombinant echistatin point out the C-terminal domain of the 
disintegrin to be a contributing factor in a5Pi binding (Wierzbicka-Patynowski et al., 
1999). In their study Wierzbicka-Paynowski et al. (1999) examined at conformation 
changes in the integrin model due to ligand binding using antibodies, called anti-ligand-
induced binding site (LIBS) antibodies, to the new binding site. They substituted the C-
terminal sequence of eristostatin (WNG) with those of echistatin (HKGPAT) and found 
that inhibitory potency of the hybrid increase was over 4-fold greater than that of the 
wild-type. This suggests that C-terminal region of the mojastin should be considered 
when producing mutant mojastin recombinants to affect apoptosis. 
The amino acids N-terminal to the RGD-loop are PARGDDM for echistatin and 
IPRGDMP for rhodostomin. Binding studies done with elegantin showed that 
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replacement of the Pro residue, N-terminal to the RGD-loop, with Ala produced peptides 
that bound with greater avidity to (X5P1, emphasizing that not only does the C-terminal 
residues flanking the RGD-loop, contribute to the binding specificity of integrins, but the 
residues N-terminal residues to the RGD-loop contribute as well (Rahman et al., 1995). 
In this mutant mojastin recombinant fusion proteins were used to study the ability 
of the 54th and 55th amino acids, C-terminal to the RGD-loop, to induce apoptosis 
signaling in HUVEC cells, containing the avP3 and a5p\ integrins. Wild-type and mutant 
mojastin recombinant fusion proteins were expressed with a molecular weight of 34 
kDA. Though these recombinant fusion proteins did not affect apoptosis signaling in 
HUVEC cells, this inactivity from exposure to the recombinant fusion proteins may be 
the result of a partial recognition sequence. The recombinant fusion proteins produced 
here only contained sequence similarity of the 54th and 55th amino acid C-terminal, to the 
RGD-loop. However, the amino acids N-terminal to the RGD-loop and the C-terminal 
region outside of the RGD-loop have also been shown to affect inhibition of platelet 
aggregation. Thus the mutant mojastin recombinant fusion proteins with the correct 
amino acids C-terminal to the RGD-loop may not be sufficient to induce apoptosis in 
HUVEC cells. 
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